Listed

Protalix BioTherapeutics, Inc.

PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31

Reports and events: 399 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Protalix BioTherapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2017-04-1207:39 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-020074
2017-03-1616:21 ETDEF 14AProxy statementPeriod 2017-04-120001144204-17-015102
2017-03-1616:08 ET10-KAnnual reportPeriod 2016-12-310001144204-17-015083
2017-03-1608:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-17-014889
2017-02-1616:31 ET8-K7.01 Regulation FD disclosure0001144204-17-009587
2017-02-1417:39 ET8-K5.08 Item not in the standard list; 9.01 Financial statements and exhibits0001144204-17-009041
2017-02-1417:20 ET8-K5.08 Item not in the standard list; 9.01 Financial statements and exhibits0001144204-17-009023
2017-01-0906:11 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-17-001203
2017-01-0307:39 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-000033
2016-12-2707:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-141308
2016-12-1407:39 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-139314
2016-12-0717:26 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001144204-16-138423
2016-12-0218:45 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-137521
2016-11-3008:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-137103
2016-11-2216:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-135929
2016-11-0916:32 ET10-QQuarterly reportPeriod 2016-09-300001144204-16-132819
2016-11-0908:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-16-132568
2016-10-2507:40 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-129272
2016-08-1007:39 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-117891
2016-08-0816:51 ET10-QQuarterly reportPeriod 2016-06-300001144204-16-117287
2016-08-0816:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-16-117272
2016-07-0707:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-111871
2016-07-0117:04 ETDEF 14AProxy statementPeriod 2016-08-070001144204-16-111273
2016-06-0709:34 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-16-107222
2016-06-0607:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-106902
2016-05-0916:32 ET10-QQuarterly reportPeriod 2016-03-310001144204-16-099933
2016-05-0907:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-16-099713
2016-04-2217:00 ET10-K/AAnnual report, amendedPeriod 2015-12-310001144204-16-095858
2016-04-0817:00 ET8-K8.01 Other events0001144204-16-093507
2016-04-0117:00 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001144204-16-092335
2016-03-0816:31 ET10-KAnnual reportPeriod 2015-12-310001144204-16-086642
2016-03-0807:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-16-086517
2016-03-0307:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-16-085676
2016-01-0416:30 ET8-K5.08 Item not in the standard list0001144204-16-073802
2015-12-1116:30 ET10-Q/AQuarterly report, amendedPeriod 2015-09-300001144204-15-070554
2015-11-2316:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-15-067493
2015-11-1607:14 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-15-065519
2015-11-0916:42 ET10-QQuarterly reportPeriod 2015-09-300001144204-15-063825
2015-11-0916:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-15-063756
2015-10-1907:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-15-059866
2015-10-1317:29 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-15-059259
2015-10-0116:30 ETDEF 14AProxy statementPeriod 2015-11-080001144204-15-057696
2015-09-0907:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-15-054121
2015-08-1016:50 ET10-QQuarterly reportPeriod 2015-06-300001144204-15-047801
2015-08-1016:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-15-047786
2015-05-0716:48 ET10-QQuarterly reportPeriod 2015-03-310001144204-15-028431
2015-05-0716:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-15-028413
2015-03-1216:45 ET10-KAnnual reportPeriod 2014-12-310001144204-15-015672
2015-03-1216:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-15-015665
2015-02-1207:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-15-008141

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.